TY - JOUR
T1 - Redefining the norms
T2 - an interdisciplinary perspective on language testing in multilinguals with acquired and progressive neurogenic disorders
AU - Hausmann, Alessa
AU - García, Adolfo M.
AU - Costa, Ana Sofia
AU - Bose, Arpita
AU - Tee, Boon Lead
AU - Rivera-Fernandez, Claudia
AU - Europa, Eduardo
AU - Kavé, Gitit
AU - Sung, Jee Eun
AU - de Oliveira, Maira Okada
AU - Wigdorowitz, Mandy
AU - Garraffa, Maria
AU - Carthery-Goulart, Maria Teresa
AU - Kleiman, Michael J.
AU - Friedmann, Naama
AU - Diouny, Samir
AU - Franzen, Sanne
AU - Toniolo, Sofia
AU - Grasso, Stephanie
AU - Bak, Thomas H.
AU - Borghesani, Valentina
N1 - © 2026 The Author(s). Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
PY - 2026/4/1
Y1 - 2026/4/1
N2 - Accurate language assessment is essential in clinical and research contexts. However, most assessment tools and questionnaires have been developed within monolingual frameworks, overlooking the particularities of the vast multilingual population and, thus, often leading to misdiagnosis and inequitable care. Here, we examine the limitations of monolingual-centric approaches to language testing in multilinguals with acquired and progressive neurogenic disorders and explore the implications of multilingualism across linguistic, cognitive, neural, clinical, and sociocultural domains. We also address the need for technological innovation and theoretical refinement to better accommodate linguistic diversity in healthcare. Ultimately, we advocate for a nuanced, equitable, and culturally sensitive model of language assessment that reflects the realities of multilingual populations by accounting for their diverse linguistic repertoires, cognitive trajectories, and neural profiles. This model integrates valid, adapted tools, inclusive normative data, and context-appropriate testing practices, with particular attention to under-represented and typologically diverse languages.
AB - Accurate language assessment is essential in clinical and research contexts. However, most assessment tools and questionnaires have been developed within monolingual frameworks, overlooking the particularities of the vast multilingual population and, thus, often leading to misdiagnosis and inequitable care. Here, we examine the limitations of monolingual-centric approaches to language testing in multilinguals with acquired and progressive neurogenic disorders and explore the implications of multilingualism across linguistic, cognitive, neural, clinical, and sociocultural domains. We also address the need for technological innovation and theoretical refinement to better accommodate linguistic diversity in healthcare. Ultimately, we advocate for a nuanced, equitable, and culturally sensitive model of language assessment that reflects the realities of multilingual populations by accounting for their diverse linguistic repertoires, cognitive trajectories, and neural profiles. This model integrates valid, adapted tools, inclusive normative data, and context-appropriate testing practices, with particular attention to under-represented and typologically diverse languages.
KW - acquired aphasia
KW - brain health equity
KW - language assessment
KW - multilingualism
KW - personalized medicine
KW - progressive neurogenic disorders
UR - https://www.scopus.com/pages/publications/105041003796
U2 - 10.1002/dad2.70366
DO - 10.1002/dad2.70366
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 42273083
AN - SCOPUS:105041003796
SN - 2352-8729
VL - 18
JO - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
JF - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
IS - 2
M1 - e70366
ER -